In this study, we aimed to optimize the pertussis toxoid (PTd) mRNA antigen in a pertussis toxin (PT) challenge mouse model followed by an evaluation of the protection afforded by a novel 10-antigen mRNA-pertussis vaccine in an aerosol challenge model of Bp in rats. This evidence concerns the gene F2 and pertussis.